Skip to content

Author

Taha Ibrahim

We have 3 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Abstract 15440: Clinical Outcomes of Drug-Coated Balloon Angioplasty Compared with Drug-Eluting Stents in Coronary Bifurcation Lesions: An Updated Systematic Review and Meta-Analysis

Background: The optimal percutaneous coronary intervention strategy for coronary bifurcation lesions remains uncertain. Drug-coated balloon (DCB) angioplasty offers a stent-less approach that may preserve vessel physiology and reduce metal burden. We performed an updated systematic review and meta-analysis comparing...

Taha Ibrahim, Muhammad Burhan, M. Naveed et al. · 0 citations
Review Oct 2026

Efficacy and safety of guselkumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.

Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBDs) driven by the interleukin-23/Th17 pathway. Guselkumab, a selective interleukin-23p19 monoclonal antibody, has shown promise in phase II/III trials. This systematic review and meta-analysis aimed to synthesize its efficacy and safety v...

Z. Shahid, M. Azam, Ahila Ali et al. · 0 citations
Review Sep 2026

Efficacy and Safety of Baxdrostat in Hypertension: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Findings strengthen the evidence for selective aldosterone synthase inhibition as a therapeutic approach for aldosterone-mediated hypertension and suggest that baxdrostat may provide an additional treatment option, particularly for patients who remain uncontrolled or cannot tolerate mineralocorticoid receptor antagonis...

Muhammad Burhan, Z. Shahid, M. Naveed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.